• Via di San Gallicano, Rome, Italy
  • (39) 06 8992225
  • dream@santegidio.org

News

Counseling about negative aspects of unsafe sex cuts HIV risky behaviors

Counseling about negative aspects of unsafe sex cuts HIV risky behaviors
Source : AIDS 2004;18:1179-1186  (2004-06-15)
NEW YORK (Reuters Health) – In motivating HIV-infected patients to reduce behaviors that may transmit the virus, brief counseling about the negative consequences of unsafe sex is more effective than discussing the positive outcomes of safer sex, according to a new study.

 

The findings, which appear in the May 21st issue of AIDS, are based on a study of 585 sexually active subjects who attended clinics emphasizing either of these risk reduction approaches or to control clinics that only stressed adherence to antiretroviral therapy.

(. . .)

Mugabe appeals for private sector help in AIDS war

Mugabe appeals for private sector help in AIDS war (2004-06-16)
HARARE (Reuters) – Zimbabwe President Robert Mugabe urged the private sector on Wednesday to help his cash-strapped government provide essential drugs to combat an AIDS pandemic he described as one of the greatest challenges facing the country.

 

Official figures show that 24.6 percent of Zimbabwe’s adult population is infected with the HIV virus that causes AIDS, one of the highest rates in the world.

(. . .)

Minor HIV protease mutations point to antiretroviral failure

Minor HIV protease mutations point to antiretroviral failure
Source : J Infect Dis 2004;189:1983-1987 
NEW YORK (Reuters Health) – Minor mutations of 36I and 101/V in HIV protease can predict the appearance of a mutation associated with resistance to protease inhibitors (PIs), European researchers report in the June 1st issue of the Journal of Infectious Diseases.

 

Dr. Carlo Federico Perno of the University of Rome Tor Vergata and colleagues, who note that 36I is seen in about 25% of HIV clade B and more than 80% of non-clade B viruses, came to this conclusion after studying 93 previously drug-naive patients who experienced failure of their first PI -based antiretroviral regimens.

(. . .)

Fuzeon should be used when CD4 counts are above 100m cells per liter

Fuzeon should be used when CD4 counts are above 100m cells per liter: panel
Source : AIDS 2004;18:1137-1146.  2004-06-22
NEW YORK (Reuters Health) – The fusion inhibitor enfuvirtide (Fuzeon) should optimally be started when CD4 cell counts are above 100 million cells per liter and virema is below 100,000 copies/mL, according to a panel of HIV-treating physicians with knowledge and experience in using the anti-HIV agent.
(. . .)

Southern Africa seen in “death spiral” on AIDS, food shortages

Southern Africa seen in "death spiral" on AIDS, food shortages
2004-06-22
JOHANNESBURG (Reuters) – Southern Africa is in a death spiral as AIDS exacerbates food shortages and government and social networks teeter close to collapse, the head of the U.N. World Food Programme (WFP) said on Tuesday.

 

"If a 747 aircraft crashed every hour, there’d be an international outcry. That’s the death toll we’re facing but there is inadequate collective outrage," WFP Executive Director James Morris said at the end of a tour in the region, the worst hit worldwide by the global AIDS epidemic.

(. . .)

OraSure gets HIV-2 test approval in US

OraSure gets HIV-2 test approval in US
2004-06-23
CHICAGO (Reuters) – U.S. regulators approved OraSure Technologies Inc.’s saliva test for detecting HIV-2, the company said on Wednesday.

 

OraSure had received approval in March for a saliva test of HIV-1 that gives quick results. With the latest U.S. Food and Drug Administration approval, OraSure said it plans to market a combined test for use in physicians’ offices and public health clinics as a rapid means of detecting HIV-1 and HIV-2.

(. . .)